arrow
I

István Vályi-Nagy

central hospital of southern pest
H指数:24
被引数:2,099

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adoptive T-cell therapies for persistent COVID-19 in immunocompromised patients: Comparison of IFN-γ virus-specific T-cell therapy and CD45RA+ T-cell depleted donor lymphocyte infusion

免疫缺陷患者持续性COVID-19的过继T细胞疗法:IFN-γ病毒特异性T细胞疗法与CD45RA+ T细胞耗竭的供者淋巴细胞输注的比较

2026-01-120
OAAI
High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infection

在抗TPO阳性甲状腺功能正常的个体中,长COVID的患病率高,SARS-CoV-2-specific T细胞反应强烈升高,感染后23个月抗尖峰IgG水平中等升高

2024-10-100
OAAI
Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary
2024-02-171
OAAI
Real-world study of vaccine effectiveness decline against SARS-Cov-2 Delta variant in COPD patients

COPD患者针对SARS-Cov-2 Delta变体的疫苗有效性下降的真实世界研究

2023-10-270
PRE
Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review
2023-07-064
OAAI
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
2023-03-2711
OAAI
Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant

加强疫苗接种可降低因SARS-CoV-2三角洲变异而住院的老年人的28天全因死亡率

2022-06-2111
OAAI
Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study

冠状病毒疾病2019 (新型冠状病毒肺炎) 入院时补体水平反映严重急性肾损伤 (AKI) 进展: 一项多中心前瞻性队列研究

2022-04-296
OAAI
Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality
2022-01-2116
OAAI